Thermo Fisher Scientific Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +54.2% | -66.4% | +56.7% | +10.5% | +51.9% | -78.0% | +93.5% | +60.0% | +54.4% | -65.5% | +78.3% | – | |
| – | -1.6% | -0.4% | -5.5% | -6.3% | +0.0% | -4.6% | -3.0% | -3.4% | +10.0% | +1.1% | +10.9% | – | |
| – | – | +14.8% | +20.0% | -19.0% | +16.2% | -5.1% | +8.0% | -13.6% | +20.0% | -1.2% | -1.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -145.7% | – | – | +1,880.0% | -339.9% | – | – | -77.3% | -327.4% | – | – | |
| – | +22.0% | -14.3% | -13.3% | -9.6% | +76.5% | -24.6% | -18.8% | +37.4% | +15.1% | -19.1% | +19.7% | – | |
| – | -92.1% | +439.9% | -87.5% | +1,314.2% | – | -2,735.0% | -45.4% | +1,331.6% | – | -1,105.7% | – | – | |
| – | +0.7% | -0.7% | +10.4% | +0.7% | -0.7% | +0.0% | +8.7% | +0.6% | -0.6% | +0.0% | +8.0% | – | |
| – | -100.0% | – | -100.0% | – | -66.7% | +100.0% | +0.0% | – | -250.0% | +0.0% | -66.7% | – | |
| – | – | – | – | – | +125.8% | – | -139.3% | – | +629.7% | +16.0% | -109.2% | – | |
| – | -177.0% | +27.5% | -93.7% | +943.9% | +208.1% | -97.2% | +871.6% | -36.2% | – | -69.0% | -335.2% | – | |
| – | -36.0% | -233.6% | – | -253.8% | – | – | +229.0% | -701.4% | – | -183.9% | – | – | |
| – | +59.4% | -72.8% | +83.5% | +14.2% | +48.4% | -87.2% | +206.1% | +66.1% | +63.1% | -72.7% | +105.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.